Trial Profile
Phase III confirmatory study on a cancer pain treatment drug, HFT 290 (a once-a-day application fentanyl citrate transdermal system)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Mar 2013
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Registrational; Therapeutic Use
- 19 Mar 2013 New trial record